The influence of estrogenic and-or progestogenic treatment on some parameters of lipid metabolism (a controlled clinical study).
D000328:Adult; D000704:Analysis of Variance; D002715:Chlormadinone Acetate / Q000494:pharmacology; D002784:Cholesterol / Q000097:blood; D002986:Clinical Trials as Topic; D004997:Ethinyl Estradiol / Q000494:pharmacology*; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005260:Female; D006801:Humans; D006914:Hydroxysteroids / Q000494:pharmacology; D050356:Lipid Metabolism; D008055:Lipids / Q000097:blood*; D008074:Lipoproteins / Q000097:blood; D008657:Metabolic Clearance Rate / Q000187:drug effects; D008875:Middle Aged; D009649:Norpregnadienes / Q000494:pharmacology*; D009650:Norpregnanes / Q000494:pharmacology*; D010743:Phospholipids / Q000097:blood; D045167:Progesterone Congeners / Q000494:pharmacology*
D005230:Fatty Acids, Nonesterified; D006914:Hydroxysteroids; D008055:Lipids; D008074:Lipoproteins; D009649:Norpregnadienes; D009650:Norpregnanes; D010743:Phospholipids; D045167:Progesterone Congeners; D002715:Chlormadinone Acetate; D004997:Ethinyl Estradiol; D002784:Cholesterol